Sjogren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases

ABSTRACT: To define the clinical and immunologic pattern of expression of Sjögren syndrome (SS) associated with chronic hepatitis C virus (HCV) infection, we conducted a multicenter study aiming to collect a large number of patients with SS and HCV infection. Inclusion criteria were the fulfillment...

Full description

Autores:
Ramos Casals, Manuel
Anaya Cabrera, Juan Manuel
Loustaud-Ratti, Veronique
De Vita, Salvatore
Zeher, Margit
Bosch, José Ángel
Toussirot, Eric
Medina, Francisco
Font Franco, Josep
Rosas, José
Tipo de recurso:
Article of investigation
Fecha de publicación:
2005
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/38747
Acceso en línea:
https://hdl.handle.net/10495/38747
Palabra clave:
Artritis
Arthritis
Autoanticuerpos
Autoantibodies
Proteínas del Sistema Complemento
Complement System Proteins
Crioglobulinemia
Cryoglobulinemia
Hepatitis C Crónica
Hepatitis C, Chronic
Hepatopatías
Liver Diseases
Síndrome de Sjögren
Sjogren's Syndrome
Enfermedades de la Piel
Skin Diseases
Vasculitis
gamma-Glutamiltransferasa
gamma-Glutamyltransferase
https://id.nlm.nih.gov/mesh/D001168
https://id.nlm.nih.gov/mesh/D001323
https://id.nlm.nih.gov/mesh/D003165
https://id.nlm.nih.gov/mesh/D003449
https://id.nlm.nih.gov/mesh/D019698
https://id.nlm.nih.gov/mesh/D008107
https://id.nlm.nih.gov/mesh/D012859
https://id.nlm.nih.gov/mesh/D012871
https://id.nlm.nih.gov/mesh/D014657
https://id.nlm.nih.gov/mesh/D005723
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
Description
Summary:ABSTRACT: To define the clinical and immunologic pattern of expression of Sjögren syndrome (SS) associated with chronic hepatitis C virus (HCV) infection, we conducted a multicenter study aiming to collect a large number of patients with SS and HCV infection. Inclusion criteria were the fulfillment of at least 4 of the classification criteria for SS proposed by the European Community Study Group and repeated positive HCV serology, confirmed by recombinant immunoblot assay and/or detection of serum HCV-RNA by polymerase chain reaction. One hundred thirty-seven patients were included (104 female and 33 male; mean age, 65 yr). Seventy-nine (58%) patients presented a systemic process with diverse extraglandular manifestations, with articular involvement (44%), vasculitis (20%), and neuropathy (16%) being the most frequent features observed. The main immunologic features were antinuclear antibodies (65%), hypocomplementemia (51%), and cryoglobulinemia (50%). Cryoglobulins were associated with a higher frequency of cutaneous vasculitis, rheumatoid factor, and hypocomplementemia. Thirty-two (23%) patients had positive anti-Ro/SS-A and/or anti-La/SS-B antibodies; these patients were predominantly women and had a higher prevalence of some extraglandular features and a lower frequency of liver involvement. Nineteen (14%) patients developed neoplasia, with hematologic neoplasia (8 cases) and hepatocellular carcinoma (6 cases) being the most frequent types. Eighty-five percent of SS-HCV patients also fulfilled the recently proposed 2002 classification criteria for SS. In conclusion, HCV-associated SS is indistinguishable in most cases from the primary form using the most recent set of classification criteria. Chronic HCV infection should be considered an exclusion criterion for the classification of primary SS, not because it mimics primary SS, but because the virus may be implicated in the development of SS in a specific subset of patients. We propose the term "SS secondary to HCV" when these patients fulfill the 2002 classification criteria for SS.